Cardinal Health Hits 52-Week High On 18.8% Q2 Sales Growth
Cardinal Health shares surged to a 52-week high after the stock jumped nearly 80% over the past year on rising volume. The company reported fiscal Q2 sales of $65.6 billion (+18.8%) and adjusted EPS of $2.63 (+36.3%), raised its full-year outlook and saw analysts boost FY26 EPS to $10.31.
1. Stock Performance Breakout
Cardinal Health shares climbed to a 52-week high after an 80% gain over the past year, supported by rising trading volume and sustained buying pressure in its healthcare services business.
2. Latest Quarterly Results
In fiscal Q2, the company reported sales of $65.6 billion, marking an 18.8% increase year-over-year, and delivered adjusted EPS of $2.63, up 36.3%, surpassing internal estimates.
3. Outlook and Analyst Revisions
Management raised the full-year outlook following the strong quarterly results, with analysts raising fiscal 2026 EPS estimates by 4.35% to $10.31, driven by specialty products targeting over $50 billion in sales.